Thromboembolic complications occupy one of the leading positions in the structure of mortality in urological patients, reaching 4–20%. According to modern literature, pulmonary embolism (PE) as a cause of death is verified in 8–35% of patients with cancer, and acts as a concomitant diagnosis in more than 43% of cases. The difficulties of the issue under consideration regarding the primary verification of the diagnosis of PE are also in the absence of adequate treatment tactics for this cohort of patients. The large volume of surgical intervention performed, as well as the violation of the parameters of the hemostatic system, induced by the primary oncoprocess limit the use of thrombolytic therapy. Antithrombotic therapy acting as a method of choice shows disappointing results, causing high mortality rates and low quality of life of the surviving patients. The surgical method for treating acute high-risk and intermediate-high-risk PE in the structure of patients with oncourological profile does not have a wide practical application, which is explained by the lack of cases of its successful use in the available literature.
- Medvedev A.P., Fedorov S.A. Successful surgical treatment of massive pulmonary embolism with simultaneous mitral valve replacement. Russian Journal of Thoracic and Cardiovascular Surgery. 2018; 60 (3): 254–60. DOI: 10.24022/ 0236-2791-2018-60-3-254-260 (in Russ.).
- Lehnert Р., Mø ller C., Mortensen J., Kjaergaard J., Olsen P.S., Carlsen J. Surgical embolectomy compared to thrombolysis in acute pulmonary embolism: morbidity andmortality. Eur. J. Cardiothorac. Surg. 2017; 51 (2): 354–61. DOI: 10.1093/ ejcts/ezw297
- Acar E., . Izci S., Inanir M., Yllmaz M.F., Izgi I.A., Kirma C. Right ventricular early inflow-outflow index – a new method for echocardiographic evaluation of right ventricle dysfunction in acute pulmonary embolism. Echocardiography. 2020; 37 (2): 223–30. DOI: 10.1111/echo.14591 [Epub ahead of print]
- Zatevakhin I.I., Tsitsiashvili M.Sh., Mishnev A.D., Trusov O.A., Matyushkin A.V. Postoperative venous thromboembolic complications, how real is the threat? Angiologiya i Sosudistaya Khirurgiya (Angiology and Vascular Surgery). 2002; 8 (1): 17–21 (in Russ.).
- Sandler D.A., Martin J.F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J. R. Soc. Med. 1989; 82 (4): 203–5.
- Mulder F.I., Bosch F.T.M., van Es N. Primary thromboprophylaxis in ambulatory cancer patients: Where do we stand? Cancers (Basel). 2020; 12 (2): E367. DOI: 10.3390/cancers 12020367
- Held N., Jung B., Sommervold L., Singh S., Kreuziger L.B. Patient safety indicator-12 rarely identifies problems with quality of care in perioperative venous thromboembolism. J. Hosp. Med. 2019; 14: E1–E6. DOI: 10.12788/jhm.3298 [Epub ahead of print]
- Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Health Professional Version. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–2020.
- Lotan T.L., Tomlins S.A., Bismar T.A., Van der Kwast T.H., Grignon D., Egevad L. et al. Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers. I. Molecular Biomarkers in Prostate Cancer. Am. J. Surg. Pathol. 2020; 44 (7): е80–6. DOI: 10.1097/PAS.0000000000001450 [Epub ahead of print]
- Chinenov D.V., Shpot E.V., Chernov Ya.N., Amosov A.V., Enikeev D.V., Krupinov G.E., Petrovskyi N.V., Olifirova K.P. Minimally invasive techniques of localized prostate cancer. Urologiya (Urology). 2019; 6: 156–64 (in Russ.). DOI: 10.18565/urology.2019.6-156-164
- Gillessen S., Omlin A., Attard G., de Bono J.S., Efstathiou E., Fizazi K. et. al. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Ann. Oncol. 2019; 30 (12): e3. DOI: 10.1093/annonc/mdw180
- Lovrenski A., Vrekić Ž., Škrbić D., Višnjić B.A., Vasilijević M., More L.V. An autopsy case of massive pulmonary tumor embolism due to undiagnosed prostatic adenocarcinoma. Forensic Sci. Med. Pathol. 2019; 16 (1): 152–6. DOI: 10.1007/s12024-019-00184-5 [Epub ahead of print]
- Catella-Chatron J., Merah A., De Magalhaes E., Moulin N., Accassat S., Duvillard C. et al. Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancerpatients. Respir. Med. Res. 2019; 76: 34–7. DOI: 10.1016/j.resmer.2019.08.002. Epub 2019 Aug 27.
- Koga M., Sugimoto A., Furo M., Iseki H. Apixaban for the treatment of cancer-associated venous thromboembolism and left atrial appendage thrombus refractory to optimal anticoagulation with warfarin: a case report. Eur. Heart J. Case Rep. 2018; 2 (4): 135. DOI: 10.1093/ehjcr/yty135. eCollection 2018 Dec.
- Felber M., Rozet F., Droupy S., Misraï V., Smadja D.M., Rouprê t M. Venous thromboembolism and urological cancer: Epidemiology and therapeutically management. Prog. Urol. 2019; 29 (1): 1–11. DOI: 10.1016/j.purol.2018.09.002. Epub 2018 Oct 10. French.
- Wu J., Chen H., Yu Y., Peng L., Li J., Liang H. et al. Feasibility of ultrasound-assisted catheter-directed thrombolysis for submassive pulmonary embolism: A meta-analysis of case series. Clin. Respir. J. 2020; 14 (5): 430–9. DOI: 10.1111/crj.13155. [Epub ahead of print].
- Koehl J.L., Hayes B.D., Al-Samkari H., Rosovsky R. A comprehensive evaluation of apixaban in the treatment of venous thromboembolism. Exp. Rev. Hematol. 2020; 23: 1–19. DOI: 10.1080/17474086.2020.1711731. [Epub ahead of print].
- Medvedev A.P., Nemirova S.V., Pichugin V.V., Shirokova O.R., Sobolev Yu.A., Penknovich A.A. et al. Open embolectomy in the treatment of massive thromboembolism of pulmonary arteries. Meditsinskiy Al'manakh (Medical Almanac). 2013; 4 (28): 57–60 (in Russ.).
About the authors
- Aleksandr P. Medvedev, Dr. Med. Sc., Professor, Cardiovascular Surgeon, ORCID
- Sergey A. Fedorov, Cand. Med. Sc., Cardiovascular Surgeon, ORCID
- Vagif A. Atduev, Dr. Med. Sc., Professor, Head of Department, ORCID
- Yuriy D. Brichkin, Dr. Med. Sc., Anesthesiologist-Resuscitator, ORCID
- Sergey A. Zhurko, Cand. Med. Sc., Cardiovascular Surgeon, ORCID
- Lada M. Tselousova, Postgraduate, Cardiovascular Surgeon, ORCID
- Il’dar V. Abdul’yanov, Cand. Med. Sc., Head of Department, ORCID